| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215908 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
Detectable EBV DNA levels and an unsatisfactory tumor response (stable disease or disease progression) after NACT serve as predictors of poor prognosis for patients with advanced-stage NPC. These findings will facilitate further risk stratification, early treatment modification, or both before CCRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Li-Ting MD, Lin-Quan MD, PhD, Qiu-Yan MD, PhD, Lu MD, Shan-Shan MD, Ling MD, PhD, Hao-Yuan MD, PhD, Chong MD, PhD, Xiang MD, PhD, Ka-Jia MD, PhD, Chao-Nan MD, PhD, Mu-Sheng MD, PhD, Jin-Xin MD, PhD, Ming-Huang MD, PhD, Jian-Yong MD, PhD, Ying MD, PhD,